Chairman of the Board - Erik Trock-Jansen

Erik Trock-Jansen holds a MBA from IMD (1989). 

Career overview:
Erik is a professional board member. Erik started his career as a management trainee with the Danish East Asiatic Company (EAC) and was after completion of his bachelor degree sent to Asia in 1982 to work with Fast Moving Consumer Goods and Healthcare in Singapore, Hong Kong and Japan. After completing his MBA Erik joined McKinsey & Co. first in Scandinavia and later in Japan. In 1995 Erik joined Ciba-Geigy/Novartis in Japan to build up a Consumer Health business. In 1998 Erik became responsible for Novartis Pharma Malaysia/Singapore. In 2002 Erik joined the Swiss DKSH Group to build up a healthcare distribution business in Taiwan. After returning to Denmark in 2007 Erik has worked as a professional board member and interim CEO focusing on healthcare. 

Other positions:
Erik is on the board of various companies either as a member or Chairman. In Malaysia Erik was vice-Chairman of the Pharmaceutical Association (PhAMA). Erik is a reserve officer of the Royal Danish Life Guard.

Vice Chairman – Peer Nørkjær

Peer Nørkjær holds a M.Sc. Pharmacy from the Copenhagen University (1978) and in addition, a M.Sc. Sales and Marketing from the Copenhagen Business School (1983). 

Career overview:
Peer started his career in ICI-Pharma Denmark (later on part of Zenica) and has had several managerial positions within different internationally renowned pharmaceutical companies, including Marketing Director Ciba-Geigy Denmark, CEO for Johnson&Johnson / Janssen-Cilag in Israel. In 1999 Peer was appointed Managing Director of Janssen-Cilag Switzerland and in 2004 he was appointed Managing Director of Janssen-Cilag Denmark. In 2007, the new chairman of the B&O Medicom board was awarded a license from the Danish ministry to become a Managing Pharmacist at Tårnby Pharmacy near Copenhagen, Denmark. 

Other positions:
Peer has been in the LIF (LIF=Danish Association of the Pharmaceutical Industry) board of directors from 1992-1996. In 1999 he was appointed Chairman of Pharma Israel and in 2006 he rejoined LIF board of directors. In 2007 he was appointed Chairman of Board for B&O Medicom. 

Member of the board – Alejandra Mørk

Alejandra Mørk holds a Ph.D. from the Royal Danish School of Pharmacy in Copenhagen (1994) and a Master of Science in Pharmacy (1985) also from the Royal Danish School of Pharmacy, Copenhagen.

Career overview:
Alejandra began her career with DAK-Laboratoriet/Nycomed in Denmark and for the past 18 years she has held a variety of positions within Nycomed in Clincal Development, Regulatory Affairs and Project Management, including Clinical Co-Ordinator (1990-1991), Head of Medical Department (1992-1994), Vice President (VP) Project Management International Product Development (1993), Director Regulatory Affairs (1994-1997), Project Management, Strategic Portfolio Management and VP International Marketing for Consumer Health Products (1997-1998) and VP Portfolio Development (1999 -2003). In 2003, Alejandra was promoted to Senior Vice President, International Product Development at Nycomed. In January 2008, Alejandra became CEO and owner of KLIFO A/S, a Danish contract research organisation (CRO) specialised in clinical research and development of pharmaceuticals, biotech products and medical devices. She was appointed to the board of directors of Bang & Olufsen Medicom in 2007.

Other positions:
Member of the Board of the Pharmaceutical Society of Denmark
Member of the Board of the limited partnership K/S Eskilstuna
Member of the advisory board for Innovationsalliancer, Tuborg Foundation and Nyx
Member of Committee on Communication Policy Committee, LIF (LIF = Danish Association of the Pharmaceutical Industry)
Member of ‘Akademiet for Tekniske Videnskaber’ 

Member of the board – Kim Bo Hansen

Director, Global Counsel at Bang & Olufsen A/S.